Trileptal: Advanced Seizure Control with Oxcarbazepine
| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.85 | $51.11 (0%) | 🛒 Add to cart |
| 90 | $0.77 | $76.66 $69.15 (10%) | 🛒 Add to cart |
| 120 | $0.73 | $102.22 $88.19 (14%) | 🛒 Add to cart |
| 180 | $0.70 | $153.33 $125.27 (18%) | 🛒 Add to cart |
| 270 | $0.67 | $229.99 $181.39 (21%) | 🛒 Add to cart |
| 360 | $0.66
Best per pill | $306.66 $236.51 (23%) | 🛒 Add to cart |
| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.00 | $60.13 (0%) | 🛒 Add to cart |
| 60 | $1.60 | $120.26 $96.21 (20%) | 🛒 Add to cart |
| 90 | $1.48 | $180.39 $133.29 (26%) | 🛒 Add to cart |
| 120 | $1.41 | $240.52 $169.36 (30%) | 🛒 Add to cart |
| 180 | $1.34 | $360.77 $241.52 (33%) | 🛒 Add to cart |
| 270 | $1.30
Best per pill | $541.16 $350.75 (35%) | 🛒 Add to cart |
| Product dosage: 600mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.34 | $100.22 (0%) | 🛒 Add to cart |
| 60 | $2.51 | $200.43 $150.32 (25%) | 🛒 Add to cart |
| 90 | $2.23 | $300.65 $200.43 (33%) | 🛒 Add to cart |
| 120 | $2.09 | $400.86 $250.54 (38%) | 🛒 Add to cart |
| 180 | $1.95 | $601.29 $350.75 (42%) | 🛒 Add to cart |
| 270 | $1.86
Best per pill | $901.94 $502.08 (44%) | 🛒 Add to cart |
Synonyms | |||
Trileptal (oxcarbazepine) is an antiepileptic drug (AED) indicated for use as monotherapy or adjunctive therapy in the treatment of partial seizures in adults and children as young as 2 years of age. Its active metabolite, 10-hydroxycarbazepine (MHD), is primarily responsible for its therapeutic effect, working to stabilize hyperexcited neural membranes and inhibit repetitive neuronal firing through blockade of voltage-sensitive sodium channels. This mechanism offers a refined approach to seizure management, providing efficacy with a potentially favorable tolerability profile compared to some older-generation anticonvulsants. It is available in tablet and oral suspension formulations for flexible dosing.
Features
- Active pharmaceutical ingredient: Oxcarbazepine
- Available in film-coated tablet strengths: 150 mg, 300 mg, 600 mg
- Available as a 60 mg/mL oral suspension for pediatric or dysphagic patients
- Metabolized primarily to the active 10-hydroxycarbazepine (MHD) compound
- Demonstrated efficacy in reducing seizure frequency in clinical trials
- Not extensively protein-bound, reducing potential for certain pharmacokinetic interactions
Benefits
- Provides effective control of partial-onset seizures with or without secondary generalization.
- Offers a generally well-tolerated therapeutic option with a lower potential for certain enzyme-inducing drug interactions than older agents.
- Flexible dosing formulations (tablets, suspension) accommodate a wide range of patients, including pediatric populations.
- May be suitable for both monotherapy and adjunctive therapy, allowing for tailored treatment plans.
- Avoids the formation of epoxide metabolites, which are associated with adverse effects in some related compounds.
Common use
Trileptal is primarily prescribed for the management of partial seizures, which may present with simple partial, complex partial, or secondarily generalized tonic-clonic manifestations. It is approved for use as initial monotherapy in adults and as adjunctive or monotherapy in pediatric patients aged 2–16 years with epilepsy. Off-label, it is sometimes used in the treatment of certain neuropathic pain conditions, such as trigeminal neuralgia, and as a mood stabilizer in bipolar disorder, though these uses are not FDA-approved and require careful clinical consideration.
Dosage and direction
Dosage must be individualized based on clinical response and tolerability. For adults initiating monotherapy, begin with 600 mg/day (300 mg BID). The dose may be increased by 300 mg/day every third day to a dose of 1200 mg/day. Many patients respond to 1200 mg/day, though some may benefit from up to 2400 mg/day. For adjunctive therapy in adults, start with 600 mg/day (300 mg BID); may increase by a maximum of 600 mg/day at approximately weekly intervals; recommended daily dose is 1200 mg/day. For pediatric patients, dosing is based on weight. Administer with or without food. Tablets should be swallowed whole; the oral suspension should be shaken well and may be mixed in a small glass of water immediately before dosing if desired.
Precautions
Hyponatremia (sodium <125 mmol/L) may occur during therapy; monitor serum sodium levels during initial treatment and periodically thereafter, especially in patients on other medications that may lower sodium or in those with conditions predisposing to hyponatremia. Serious dermatological reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported; discontinue if a rash develops. May cause dizziness and somnolence; advise patients to exercise caution when operating machinery or driving until they know how the medication affects them. Suicidal behavior and ideation have been reported with antiepileptic drugs; monitor patients for emergence or worsening of depression, suicidal thoughts, or unusual changes in mood or behavior. Withdraw gradually to minimize the potential of increased seizure frequency.
Contraindications
Trileptal is contraindicated in patients with a known hypersensitivity to oxcarbazepine or to any of its excipients. It should not be used in patients who have demonstrated hypersensitivity to carbamazepine, as there is approximately a 25–30% cross-reactivity risk for dermatological reactions. Do not use in patients with a history of serious hematological reaction to carbamazepine.
Possible side effect
Common adverse reactions (≥5% and greater than placebo) include: dizziness, somnolence, diplopia, fatigue, nausea, vomiting, ataxia, abnormal vision, abdominal pain, tremor, dyspepsia, and abnormal gait. Hyponatremia may occur and can be asymptomatic or present with nausea, malaise, headache, lethargy, or confusion. Less commonly, multiorgan hypersensitivity reactions, systemic lupus erythematosus, arrhythmias, and hepatitis have been reported.
Drug interaction
Coadministration may decrease the effectiveness of hormonal contraceptives; additional non-hormonal forms of contraception are recommended. May reduce plasma levels of felodipine and other dihydropyridine calcium channel blockers. Strong CYP3A4 inducers (e.g., carbamazepine, phenytoin) may decrease MHD levels. Oxcarbazepine can inhibit CYP2C19 and induce CYP3A4/5, potentially affecting drugs metabolized by these enzymes. Use caution with other CNS depressants due to additive sedative effects.
Missed dose
If a dose is missed, it should be taken as soon as possible. However, if it is almost time for the next dose, the missed dose should be skipped and the regular dosing schedule resumed. Do not double the dose to make up for a missed one.
Overdose
Symptoms of overdose may include drowsiness, dizziness, nausea, vomiting, hyperkinesia, hyponatremia, ataxia, nystagmus, blurred vision, diplopia, coma, and convulsions. There is no specific antidote. Provide supportive care, including monitoring of vital signs and observation of clinical status. Consider gastric lavage if presented early. Hemodialysis may be effective due to the moderate dialyzability of MHD.
Storage
Store tablets and oral suspension at 25°C (77°F); excursions permitted to 15–30°C (59–86°F). Keep the oral suspension in the original bottle with the cap tightly closed. Use within 7 weeks of first opening the bottle. Keep all medications out of the reach of children and pets.
Disclaimer
This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions regarding a medical condition or before starting or changing any treatment regimen. Do not disregard professional medical advice or delay seeking it because of something you have read here.
Reviews
“Trileptal has been a cornerstone in my practice for managing partial seizures, particularly in patients who did not tolerate carbamazepine well. The lower incidence of certain adverse effects and drug interactions makes it a valuable option.” – Neurologist, 15 years experience.
“In pediatric epilepsy, the availability of an oral suspension is crucial. I’ve observed good efficacy with Trileptal, though monitoring for hyponatremia is essential, especially in younger children.” – Pediatric Neurologist.
“While effective, some of my patients report dizziness and fatigue during the titration phase. Slower dose escalation seems to mitigate this for many.” – Epileptologist.
“Used it adjunctively in treatment-resistant cases. Not a magic bullet, but it provided meaningful seizure reduction for several patients with fewer cognitive side effects than some alternatives.” – Clinical Neurophysiologist.